Alyeska Investment Group, L.P. - OXFORD IMMUNOTEC GLOBAL PLC ownership

OXFORD IMMUNOTEC GLOBAL PLC's ticker is OXFD and the CUSIP is G6855A103. A total of 86 filers reported holding OXFORD IMMUNOTEC GLOBAL PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of OXFORD IMMUNOTEC GLOBAL PLC
ValueSharesWeighting
Q4 2020$23,430,000
-5.0%
1,341,518
-36.4%
0.33%
-11.7%
Q3 2020$24,662,000
+0.5%
2,107,899
+11.7%
0.38%
+0.8%
Q2 2020$24,541,000
+82.6%
1,887,731
+30.0%
0.37%
+38.8%
Q1 2020$13,442,000
-37.7%
1,451,644
+11.7%
0.27%
-5.6%
Q4 2019$21,572,000
-28.0%
1,299,500
-27.9%
0.28%
-34.4%
Q3 2019$29,961,000
+32.0%
1,801,648
+9.2%
0.43%
+47.8%
Q2 2019$22,702,000
+82.8%
1,649,846
+128.9%
0.29%
+78.7%
Q1 2019$12,420,000
-26.3%
720,848
-45.3%
0.16%
-33.1%
Q4 2018$16,847,000
-35.1%
1,318,265
-17.6%
0.24%
-14.0%
Q3 2018$25,977,000
+24.8%
1,600,544
-0.8%
0.28%
+52.4%
Q2 2018$20,807,000
+7.0%
1,614,215
+3.3%
0.19%
+16.1%
Q1 2018$19,448,000
-0.6%
1,562,056
+11.5%
0.16%
+3.2%
Q4 2017$19,571,000
-14.1%
1,400,903
+3.3%
0.16%
-8.2%
Q3 2017$22,773,000
+43.8%
1,355,529
+44.0%
0.17%
+28.8%
Q2 2017$15,838,000
+7.3%
941,625
-1.1%
0.13%
+10.0%
Q1 2017$14,754,000
+13.6%
952,469
+9.6%
0.12%
+11.1%
Q4 2016$12,991,000
+20.7%
868,965
+1.4%
0.11%
+8.0%
Q3 2016$10,762,000
+46.2%
856,878
+4.8%
0.10%
+44.9%
Q2 2016$7,359,000
-7.3%
817,691
+2.1%
0.07%
-5.5%
Q1 2016$7,939,000
-12.7%
801,101
+1.3%
0.07%
-24.7%
Q4 2015$9,095,000
-25.9%
790,866
-13.0%
0.10%
-32.6%
Q3 2015$12,276,000
-48.8%
909,331
-47.5%
0.14%
+3.6%
Q2 2015$23,988,000
+100.0%
1,732,052
+103.3%
0.14%
-16.3%
Q1 2015$11,996,000
+152.2%
851,997
+143.9%
0.17%
+104.9%
Q4 2014$4,757,000
-5.9%
349,275
+5.5%
0.08%
-22.1%
Q3 2014$5,053,000
-13.4%
330,912
-4.5%
0.10%
-20.0%
Q2 2014$5,833,000
-12.0%
346,562
+4.9%
0.13%
-28.6%
Q1 2014$6,632,000
-25.8%
330,433
-28.3%
0.18%
-48.4%
Q4 2013$8,936,000461,0850.35%
Other shareholders

There were no reported owners of OXFORD IMMUNOTEC GLOBAL PLC in Q2 2019.

NameSharesValueWeighting ↓
View complete list of OXFORD IMMUNOTEC GLOBAL PLC shareholders